IPF: New insight in diagnosis and prognosis

Respiratory Medicine
A Caminati, S Harari

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive parenchymal lung disease of unknown etiology and poor prognosis; effective therapy has remained elusive and the pathogenesis enigmatic. It has become clearer that a marked heterogeneity in disease progression exists in IPF patients. The factors affecting the prognosis of patients with IPF are poorly understood. Poor prognosis has been associated with older age, male gender, lower FVC, lower diffusing capacity of the lung for carbon monoxide (DLCO), desaturation during exercise, and the extent of fibrosis seen on imaging studies. Data from placebo-controlled trials have demonstrated that deterioration in the conditions of IPF patients over time may not be linear. These data have highlighted the concept and importance of acute exacerbations. Rapid respiratory decompensation may be more important than previously appreciated. The development of pulmonary arterial hypertension (PAH) in patients with pulmonary fibrosis is well recognized. The six-minute-walk test has emerged as an important addition to prognostic evaluation, with significant oxygen desaturation identifying a subgroup of patients with a much higher mortality. It is not yet known whether this observation denotes inci...Continue Reading

References

Sep 1, 1986·Radiology·N L MüllerD N Ostrow
Aug 1, 1995·American Journal of Respiratory and Critical Care Medicine·F X McCormackF X McCormac
Dec 1, 1993·AJR. American Journal of Roentgenology·A U WellsD M Hansell
Feb 1, 1994·American Journal of Respiratory and Critical Care Medicine·D A SchwartzG W Hunninghake
Feb 1, 1994·American Journal of Respiratory and Critical Care Medicine·D A SchwartzG W Hunninghake
Jan 1, 1997·AJR. American Journal of Roentgenology·M AkiraS Yamamoto
Dec 10, 1999·American Journal of Respiratory and Critical Care Medicine·K E GreeneT R Martin
Jul 4, 2001·American Journal of Respiratory and Critical Care Medicine·N MogulkocUNKNOWN Greater Manchester Pulmonary Fibrosis Consortium
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·K R FlahertyF J Martinez
Feb 28, 2002·The European Respiratory Journal·K R FlahertyF J Martinez
May 23, 2002·American Journal of Respiratory and Critical Care Medicine·Mohammad R Khoshnevis
Jul 18, 2002·American Journal of Respiratory and Critical Care Medicine·Andrew G NicholsonAthol U Wells
Jan 14, 2003·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN American College of Chest Physicians
May 30, 2003·American Journal of Respiratory and Critical Care Medicine·Harold R CollardKevin K Brown
May 30, 2003·American Journal of Respiratory and Critical Care Medicine·Kevin R FlahertyFernando J Martinez
Sep 4, 2003·The European Respiratory Journal·S VeeraraghavanR M du Bois
Nov 19, 2003·The European Respiratory Journal·V AmbrosiniV Poletti
Oct 1, 1950·Diseases of the Chest·J W PEABODYE W HAYES
Aug 28, 2004·Clinics in Chest Medicine·Vibha N Lama, Fernando J Martinez
Jan 11, 2005·The European Respiratory Journal·T S HallstrandG Raghu
Jan 11, 2005·American Journal of Respiratory and Critical Care Medicine·Yangjin JegalThomas V Colby
Jan 25, 2005·American Journal of Respiratory and Critical Care Medicine·Arata AzumaShoji Kudoh
Jun 22, 2005·Annals of Internal Medicine·Fernando J MartinezUNKNOWN IPF Study Group
Sep 16, 2005·Chest·Hiroshi KuboHidetada Sasaki
Oct 8, 2005·Respiration; International Review of Thoracic Diseases·Rollin P TabuenaMichiaki Mishima
Oct 21, 2005·Chest·Hassan F NadrousJay H Ryu
Nov 24, 2005·AJR. American Journal of Roentgenology·Carolina Althoff SouzaAndrew Churg
Dec 17, 2005·Internal Medicine·Sakae HommaKunihiko Yoshimura
Jan 3, 2006·The European Respiratory Journal·D S KimT Colby
Jan 24, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D J LedererS M Kawut
Feb 24, 2006·Proceedings of the American Thoracic Society·Fernando J Martinez
Jun 2, 2006·Proceedings of the American Thoracic Society·Dong Soon KimTalmadge E King

❮ Previous
Next ❯

Citations

Jan 23, 2016·Scientific Reports·Nimali P WithanaMatthew Bogyo
Nov 8, 2012·Respiratory Medicine·Young Sik ParkChul-Gyu Yoo
Feb 4, 2016·PloS One·Sergio HarariGiancarlo Cesana
Dec 12, 2017·F1000Research·Chiara ScelfoSergio Harari
Mar 28, 2018·Respiration; International Review of Thoracic Diseases·Sergio HarariUNKNOWN for the ILDINET (Interstitial Lung Diseases Italian Network)
Feb 25, 2017·The European Respiratory Journal·Ada E M BloemMartijn A Spruit
Jan 27, 2018·The European Respiratory Journal·Sara ContiFabiana Madotto
Sep 22, 2019·Internal and Emergency Medicine·Sergio HarariFrancesco Lapi
Jun 26, 2015·Expert Review of Clinical Pharmacology·Andrea S Melani
Jun 17, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Monte E TurnerAmy Milsted

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Respiratory and Critical Care Medicine
Malgorzata WygreckaP Markart
Proceedings of the National Academy of Sciences of the United States of America
S NystedtJ Sundelin
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
Jing XiongZhenqiong Li
© 2021 Meta ULC. All rights reserved